CONNECT WITH US
HealthTech

HealthTech

This time, the virus is on the patient's side. AI helped design it

Medical Xpress logo

Published on

Add as a preferred source on Google
This time, the virus is on the patient's side. AI helped design it

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

AI can write emails, create seasoning blends or put pets in Renaissance outfits. One adventurous baker used ChatGPT to concoct a cake from sauerkraut and seaweed. Now, there's an AI-made virus on the scene.

And no, it's not time to run for cover or dig out your face mask. While some viruses can make you sick, others—known as bacteriophages—cure disease by invading harmful bacteria.

In October, the biotech company Radical Numerics reported the first use of AI-designed viruses in a patient with an antibiotic-resistant infection. The team used a model called Omnii to design them. The work was a collaboration with another biotechnology company, Tabula Bioscience, which led the broader effort, according to Radical Numerics.

For decades, doctors have relied on antibiotics to treat illnesses like strep throat and bacterial pneumonia.

"They were called the magic bullet," said Northeastern biotechnology professor Sudhakaran Prabakaran. But bacteria evolved ways to survive. More than 9.3 million drug-resistant infections occur in the U.S. each year, according to the Centers for Disease Control and Prevention, the nation's health protection agency. Radical Numerics warns that antibiotic resistance could claim nearly 40 million lives between 2025 and 2050.

Bacteriophages, or phages for short, give the disease-fighting task force some much-needed backup. The trick is finding one that attacks the particular strain making a patient sick.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.